These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34716429)

  • 1. The E3 ligase COP1 promotes ERα signaling and suppresses EMT in breast cancer.
    Tang SC; Lion Q; Peulen O; Chariot P; Lavergne A; Mayer A; Fuster PA; Close P; Klein S; Florin A; Büttner R; Nemazanyy I; Shostak K; Chariot A
    Oncogene; 2022 Jan; 41(2):173-190. PubMed ID: 34716429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.
    Ramamoorthy S; Tufail R; Hokayem JE; Jorda M; Zhao W; Reis Z; Nawaz Z
    Breast Cancer Res Treat; 2012 Feb; 132(1):97-108. PubMed ID: 21553290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α.
    Tang J; Luo Y; Tian Z; Liao X; Cui Q; Yang Q; Wu G
    Neoplasia; 2020 Sep; 22(9):343-351. PubMed ID: 32599554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis.
    Shao J; Teng Y; Padia R; Hong S; Noh H; Xie X; Mumm JS; Dong Z; Ding HF; Cowell J; Kim J; Han J; Huang S
    Neoplasia; 2013 Sep; 15(9):1075-85. PubMed ID: 24027432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
    Ka WH; Cho SK; Chun BN; Byun SY; Ahn JC
    Breast Cancer; 2018 Sep; 25(5):529-538. PubMed ID: 29516369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
    Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
    Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
    Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
    Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.
    Zhu J; Zhao C; Kharman-Biz A; Zhuang T; Jonsson P; Liang N; Williams C; Lin CY; Qiao Y; Zendehdel K; Strömblad S; Treuter E; Dahlman-Wright K
    Oncogene; 2014 Aug; 33(34):4340-51. PubMed ID: 24441041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.
    Wang X; Yang Z; Zhang H; Ding L; Li X; Zhu C; Zheng Y; Ye Q
    Biochim Biophys Acta; 2008 Jun; 1783(6):1220-8. PubMed ID: 18302941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1.
    Savio MG; Rotondo G; Maglie S; Rossetti G; Bender JR; Pardi R
    Oncogene; 2008 Apr; 27(17):2401-11. PubMed ID: 17968316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor SAHA induces ERalpha degradation in breast cancer MCF-7 cells by CHIP-mediated ubiquitin pathway and inhibits survival signaling.
    Yi X; Wei W; Wang SY; Du ZY; Xu YJ; Yu XD
    Biochem Pharmacol; 2008 May; 75(9):1697-705. PubMed ID: 18342836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liganded ERα Stimulates the E3 Ubiquitin Ligase Activity of UBE3C to Facilitate Cell Proliferation.
    Okada M; Ohtake F; Nishikawa H; Wu W; Saeki Y; Takana K; Ohta T
    Mol Endocrinol; 2015 Nov; 29(11):1646-57. PubMed ID: 26389696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ubiquitin Ligase COP1 Promotes Glioma Cell Proliferation by Preferentially Downregulating Tumor Suppressor p53.
    Zou S; Zhu Y; Wang B; Qian F; Zhang X; Wang L; Fu C; Bao H; Xie M; Gao S; Yu R; Shi H
    Mol Neurobiol; 2017 Sep; 54(7):5008-5016. PubMed ID: 27534417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitin ligase RNF2 stabilizes ERα and modulates breast cancer progression.
    Yuan L; Li X; Yang H; Li H
    Hum Cell; 2023 Jan; 36(1):353-365. PubMed ID: 36271315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXK2 transcription factor suppresses ERα-positive breast cancer cell growth through down-regulating the stability of ERα via mechanism involving BRCA1/BARD1.
    Liu Y; Ao X; Jia Z; Bai XY; Xu Z; Hu G; Jiang X; Chen M; Wu H
    Sci Rep; 2015 Mar; 5():8796. PubMed ID: 25740706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability.
    Su CH; Zhao R; Zhang F; Qu C; Chen B; Feng YH; Phan L; Chen J; Wang H; Wang H; Yeung SC; Lee MH
    Cancer Res; 2011 Feb; 71(3):884-94. PubMed ID: 21135113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Molecular Mechanism To Switch the Aryl Hydrocarbon Receptor from a Transcription Factor to an E3 Ubiquitin Ligase.
    Luecke-Johansson S; Gralla M; Rundqvist H; Ho JC; Johnson RS; Gradin K; Poellinger L
    Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation.
    Ito I; Hanyu A; Wayama M; Goto N; Katsuno Y; Kawasaki S; Nakajima Y; Kajiro M; Komatsu Y; Fujimura A; Hirota R; Murayama A; Kimura K; Imamura T; Yanagisawa J
    J Biol Chem; 2010 May; 285(19):14747-55. PubMed ID: 20207742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells.
    Basak P; Chatterjee S; Bhat V; Su A; Jin H; Lee-Wing V; Liu Q; Hu P; Murphy LC; Raouf A
    Cell Physiol Biochem; 2018; 51(4):1518-1532. PubMed ID: 30497079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF8 identified as a co-activator of estrogen receptor α promotes cell growth in breast cancer.
    Wang S; Luo H; Wang C; Sun H; Sun G; Sun N; Zeng K; Song H; Zou R; Zhou T; Cong R; Liu W; Yang L; Li D; Zhou X; Zhong X; Lin L; Jiao J; Yan G; Wang X; Min X; Cao L; Zhao Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1615-1628. PubMed ID: 28216286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.